OMIC Overview
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading chart...
The current price of OMIC is 0 USD — it has increased 0
Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. The Company has developed NGS technology (Sequencing Engine), which is a platform technology for its products. The core of its Sequencing Engine is comprised of chemistry, including chemical compounds, polymers, and enzymes. Its product pipeline comprises two products, which include the G4 Sequencing Platform (G4) and the PX system (the PX). The G4 platform is a benchtop genomic sequencer designed to produce fast and accurate results. The G4 is designed to target the NGS market for particular applications. The PX is its second product in development and is a multiomics platform designed to target the markets for single-cell, spatial analysis and proteomics. Its PX platform leverages its sequencing technology, applying it as an in-situ readout to look at ribonucleic acid (RNA) and proteins in single cells and tissues.
Wall Street analysts forecast OMIC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for OMIC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Singular Genomics Systems Inc revenue for the last quarter amounts to 406.00K USD, decreased -12.12
Singular Genomics Systems Inc. EPS for the last quarter amounts to -6.72 USD, increased 2067.74
Singular Genomics Systems Inc (OMIC) has 255 emplpoyees as of June 20 2026.
Today OMIC has the market capitalization of 23.02M USD.
